LPL Financial’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
DCM
ACA
DTC
OCA
CC
LPL Financial's DFTX Position: Q1 2026 in Review
LPL Financial increased its Definium Therapeutics (DFTX) stake by 1.3% in Q1 2026, buying an estimated $17.6K and bringing the position to 78,271 shares worth $1.48M. The position accounts for ﹤0.01% of the portfolio, ranked #3799.
LPL Financial first reported a position in DFTX in Q2 2021 and has held it in 19 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.
- LPL Financial held 78,271 shares of Definium Therapeutics worth $1.48M as of Q1 2026.
- LPL Financial bought 1,035 Definium Therapeutics shares in Q1 2026, an estimated $17.6K.
- Definium Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #3799 holding.
- LPL Financial first reported a position in Definium Therapeutics in Q2 2021 and has held it in 19 quarters since.
- 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.
Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.